375 related articles for article (PubMed ID: 34724540)
1. Collateral Vessel Development in Central and Branch Retinal Vein Occlusions Are Associated With Worse Visual and Anatomic Outcomes.
Arrigo A; Aragona E; Lattanzio R; Scalia G; Bandello F; Parodi MB
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):1. PubMed ID: 34724540
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).
Kornhauser T; Schwartz R; Goldstein M; Neudorfer M; Loewenstein A; Barak A
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):835-44. PubMed ID: 26269374
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome.
Farinha C; Marques JP; Almeida E; Baltar A; Santos AR; Melo P; Costa M; Figueira J; Cachulo ML; Pires I; Silva R
Ophthalmic Res; 2015; 55(1):10-8. PubMed ID: 26540281
[TBL] [Abstract][Full Text] [Related]
6. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.
Dărăbuș DM; Pac CP; Roşca C; Munteanu M
Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516
[No Abstract] [Full Text] [Related]
7. Short-term efficacy and safety of ranibizumab for macular oedema secondary to retinal vein occlusion in Japanese patients.
Kamei M; Terasaki H; Yoshimura N; Shiraga F; Ogura Y; Grotzfeld AS; Pilz S; Ishibashi T
Acta Ophthalmol; 2017 Feb; 95(1):e29-e35. PubMed ID: 27654837
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study.
Rouvas A; Petrou P; Vergados I; Pechtasides D; Liarakos V; Mitsopoulou M; Ladas I
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1609-16. PubMed ID: 19609550
[TBL] [Abstract][Full Text] [Related]
9. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab.
Spooner K; Fraser-Bell S; Hong T; Chang A
Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
[TBL] [Abstract][Full Text] [Related]
12. Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with Ranibizumab.
Sophie R; Wang PW; Channa R; Quezada-Ruiz C; Clark A; Campochiaro PA
Ophthalmology; 2019 Dec; 126(12):1695-1702. PubMed ID: 31543350
[TBL] [Abstract][Full Text] [Related]
13. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Jumper JM; Figueroa M;
Ophthalmology; 2009 Mar; 116(3):504-12. PubMed ID: 19167078
[TBL] [Abstract][Full Text] [Related]
14. Collateral vessel presence in branch and central retinal vein occlusions and their impact on visual acuity and anatomical gains: a retrospective analysis.
Singh RP; Lee TJ; Yau L; Rubio RG
Retina; 2014 Nov; 34(11):2242-9. PubMed ID: 25046394
[TBL] [Abstract][Full Text] [Related]
15. Results of bevacizumab as the primary treatment for retinal vein occlusions.
Figueroa MS; Contreras I; Noval S; Arruabarrena C
Br J Ophthalmol; 2010 Aug; 94(8):1052-6. PubMed ID: 20679089
[TBL] [Abstract][Full Text] [Related]
16. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
[TBL] [Abstract][Full Text] [Related]
17. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
[TBL] [Abstract][Full Text] [Related]
18. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T
Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
